Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of Repeat Intramuscular ABP-450 (prabotulinumtoxinA) Injection for the Treatment of Cervical Dystonia

NCT04871451 is registered in ClinicalTrials.gov with AEON Biopharma, Inc. as lead sponsor.

NCT NCT04871451
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04871451 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of Repeat Intramuscular ABP-450 (prabotulinumtoxinA) Injection for the Treatment of Cervical Dystonia
Lead sponsor
AEON Biopharma, Inc.
Phase
Phase 2
Overall status
Completed
Start date
July 27, 2021
Completion date
July 24, 2023
Enrollment
51 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

cervical dystonia